Ceftolozane-Tazobactam Resistance in Multidrug-Resistant Pseudomonas aeruginosa Isolates Not Associated with AmpC Activity

BACKGROUND: Ceftolozane-tazobactam (CT) is a newly approved cephalosporin/β-lactamase inhibitor combination with excellent in vitro activity against multidrug-resistant (MDR) P. aeruginosa. Unfortunately, CT-resistance (CT-R) has already been reported. In this work, we evaluate mutational pathways a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Tran, Truc T, Diaz, Lorena, Abodakpi, Henrietta, Ardila, Javier, Cadena, Elsa De La, Rios, Rafael, Miller, William, Rivas, Lina, Dinh, An, Porras, Paola, Panesso, Diana, Tam, Vincent, Munita, Jose M, Arias, Cesar
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631879/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.175
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki